Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4000)
All Articles published online
|
Mar 15, 2010 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Filippatos TD, Elisaf MS. Combination drug treatment in obese diabetic patients. World J Diabetes 2010; 1(1): 8-11 [PMID: 21537422 DOI: 10.4239/wjd.v1.i1.8] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v1/i1/8.htm |
| Number | Citing Articles |
| 1 |
Theodosios D. Filippatos, Evangelos N. Liberopoulos, Moses S. Elisaf. Dapagliflozin in patients with type 2 diabetes mellitus. Therapeutic Advances in Endocrinology and Metabolism 2015; 6(1): 29 doi: 10.1177/2042018814558243
|
| 2 |
Theodosios D Filippatos, Moses S Elisaf. Safety considerations with fenofibrate/simvastatin combination. Expert Opinion on Drug Safety 2015; 14(9): 1481 doi: 10.1517/14740338.2015.1056778
|
| 3 |
Theodosios Filippatos, Eleftheria Tzavella, Christos Rizos, Moses Elisaf, George Liamis. Acid-base and electrolyte disorders associated with the use of antidiabetic drugs. Expert Opinion on Drug Safety 2017; 16(10): 1121 doi: 10.1080/14740338.2017.1361400
|
| 4 |
Anastazia A. Kei, Theodosios D. Filippatos, Vasilios Tsimihodimos, Moses S. Elisaf. A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease. Metabolism 2012; 61(7): 906 doi: 10.1016/j.metabol.2011.12.002
|
| 5 |
Theodosios D Filippatos, Vasilios G Athyros, Moses S Elisaf. The pharmacokinetic considerations and adverse effects of DDP-4 inhibitors. Expert Opinion on Drug Metabolism & Toxicology 2014; 10(6): 787 doi: 10.1517/17425255.2014.907274
|
| 6 |
Vasilios Tsimihodimos, Theodosios D. Filippatos, Moses S. Elisaf. Effects of sodium-glucose co-transporter 2 inhibitors on metabolism: unanswered questions and controversies. Expert Opinion on Drug Metabolism & Toxicology 2017; 13(4): 399 doi: 10.1080/17425255.2017.1258055
|
| 7 |
Theodosios D. Filippatos, Angelos Liontos, Ioanna Papakitsou, Moses S. Elisaf. SGLT2 inhibitors and cardioprotection: a matter of debate and multiple hypotheses. Postgraduate Medicine 2019; 131(2): 82 doi: 10.1080/00325481.2019.1581971
|
| 8 |
Review on Good Laboratory Practices. International Journal of Advanced Research in Science, Communication and Technology 2023; : 338 doi: 10.48175/IJARSCT-8307
|